balance equationreview2026-06-30
Difference 74700000 exceeds tolerance 10200400.000. Presentation or filing-vintage differences need review.
Revenue
$5.81B
Fiscal year ended 2026-06-30Operating income
-$81.50M
Fiscal year ended 2026-06-30Free cash flow
Unavailable
Fiscal year ended 2026-06-30Valuation, from the filing
| Public float | $1.10B | Market value of stock held by non-affiliates, as stated on the cover page for 2025-12-31 |
|---|---|---|
| Float per share | $1.25 | Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself. |
| Float / revenue | 0.2× | A lower bound on the multiple, because affiliate holdings are excluded. |
| Float / equity | 0.3× | A lower bound on the multiple, because affiliate holdings are excluded. |
Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-12-31, not today, and each multiple below it uses the figures for the fiscal year ending 2026-06-30 — the year that filing covered.
Valuation over time
54.8× earnings today, against a median of 15.0× across 3 years on record. Above its own history.
| Float measured | Public float | Float / net income | |
|---|---|---|---|
| 2023-12-31 | $4.90B | 54.8× | |
| 2022-12-31 | $3.10B | 6.1× | |
| 2021-12-31 | $3.90B | 15.0× |
Each float is paired with the fiscal year the filing that stated it covers. Only years where the company reported positive net income appear, because a multiple against a loss is not a multiple.
How this compares in its industry
Percentile among the Perfumes, Cosmetics & Other Toilet Preparations filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.
| Measure | Reported | Percentile | |
|---|---|---|---|
| Current ratio | 0.75x | 13th | |
| SBC / revenue | 0.8% | 18th | |
| Gross margin | 62.9% | 73th | |
| Operating margin | -1.4% | 29th | |
| Revenue YoY growth | -1.5% | 31th | |
| Long-term debt / equity | 0.96x | 67th | |
| R&D / revenue | 2.1% | 33th | |
| Net margin | -10.4% | 36th |
COTY INC. (COTY) reported revenue of $5.81B and net income of -$604.80M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from COTY INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Perfumes, Cosmetics & Other Toilet Preparations.
Income
| Metric | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.81B | $5.89B | $6.12B | $5.55B | $5.30B | $4.63B | $4.72B | $6.29B | $6.84B | $7.65B |
| Cost of revenue | $2.15B | $2.07B | $2.18B | $2.01B | $1.94B | $1.86B | $1.99B | $2.50B | $2.72B | $3.03B |
| Gross profit | $3.65B | $3.82B | $3.94B | $3.55B | $3.37B | $2.77B | $2.73B | $3.79B | $4.12B | $4.62B |
| Operating income | -$81.50M | $241.10M | $546.70M | $543.70M | $240.90M | -$48.60M | -$1.24B | -$3.69B | -$155.50M | -$420.90M |
| Net income | -$604.80M | -$367.90M | $89.40M | $508.20M | $259.50M | -$201.30M | -$1.01B | -$3.78B | -$168.80M | -$422.20M |
| Research & development | $121.20M | $123.00M | $126.80M | $105.20M | $97.30M | $96.50M | $93.40M | $98.50M | $108.10M | $139.20M |
| Weighted-average diluted shares | shares 877.40M | shares 870.90M | shares 883.40M | shares 886.50M | shares 834.10M | shares 764.80M | shares 759.10M | shares 751.20M | shares 749.70M | shares 642.80M |
| Pretax income | -$610.20M | -$344.80M | $204.50M | $704.80M | $426.80M | -$239.80M | -$1.47B | -$3.95B | -$394.50M | -$658.00M |
| Income tax expense | -$20.00M | $5.40M | $95.10M | $181.60M | $164.80M | -$172.00M | -$377.70M | -$54.80M | -$32.20M | -$259.50M |
| Diluted EPS | $-0.70 | $-0.44 | $0.09 | $0.57 | $0.08 | $-0.40 | $-1.33 | $-5.04 | $-0.23 | $-0.66 |
| Selling, general & administrative | $3.11B | $3.10B | $3.16B | $2.82B | $2.88B | $2.36B | $3.12B | $3.47B | $3.81B | $4.04B |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $176.10M | $257.10M | $300.80M | $246.90M | $233.30M | $253.50M | $308.30M | $340.40M | $331.60M | $535.40M |
| Total assets | $10.20B | $11.91B | $12.08B | $12.66B | $12.12B | $13.69B | $16.73B | $17.71B | $22.63B | $22.55B |
| Current assets | $1.92B | $1.95B | $1.96B | $2.05B | $1.68B | $1.78B | $6.50B | $3.27B | $3.65B | $3.58B |
| Total liabilities | $6.82B | $7.95B | $7.83B | $8.43B | $8.56B | $9.51B | $12.71B | $12.66B | $13.11B | $12.68B |
| Current liabilities | $2.54B | $2.54B | $2.60B | $2.74B | $2.57B | $2.42B | $3.59B | $3.48B | $4.04B | $3.80B |
| Total equity incl. NCI | $3.16B | $3.72B | $4.01B | $4.00B | $3.35B | $3.06B | $3.23B | $4.59B | $8.86B | $9.32B |
| Temporary (mezzanine) equity | $142.40M | $142.40M | $142.40M | $142.40M | $142.40M | $1.04B | $715.80M | $0 | $0 | $0 |
| Inventory | $838.70M | $794.50M | $764.10M | $853.40M | $661.50M | $650.80M | $678.20M | $860.10M | $1.15B | $1.05B |
| Accounts receivable | $525.80M | $526.40M | $441.60M | $360.90M | $364.60M | $348.00M | $440.10M | $858.90M | $1.54B | $1.47B |
| Goodwill | $3.81B | $4.06B | $3.91B | $3.99B | $3.91B | $4.12B | $3.97B | $4.17B | $7.60B | $8.56B |
| Long-term debt | $3.03B | $3.96B | $3.84B | $4.18B | $4.41B | $5.40B | $7.89B | $7.47B | $7.31B | $6.93B |
| Accounts payable | Unavailable | Unavailable | $1.41B | $1.44B | $1.27B | $1.17B | $1.19B | $1.58B | $1.93B | $1.73B |
Cash flow
| Metric | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $537.80M | $492.60M | $614.60M | $625.70M | $726.60M | $318.70M | -$50.90M | $639.60M | $413.70M | $757.50M |
| Capital expenditures | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Investing cash flow | $539.00M | -$128.40M | -$226.20M | -$118.20M | $269.70M | $2.44B | -$833.40M | -$454.00M | -$687.60M | -$1.16B |
| Financing cash flow | -$1.16B | -$426.80M | -$336.70M | -$469.30M | -$1.03B | -$2.80B | $877.30M | -$160.30M | $69.30M | $595.20M |
| Net change in cash | -$81.50M | -$50.20M | $36.80M | $20.00M | -$46.60M | -$41.60M | -$28.40M | $18.20M | -$208.50M | $198.30M |
| Stock-based compensation | $46.30M | $50.00M | $88.80M | $135.90M | $195.50M | $29.90M | $29.80M | $14.80M | $30.60M | $24.60M |
| Common dividends paid | $13.20M | $13.30M | $13.40M | $13.70M | $57.20M | $25.70M | $195.20M | $345.00M | $374.90M | $372.60M |
| Common share repurchases | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $0 | $4.50M | $0 | $0 | $36.30M |
| Depreciation & amortization | $482.20M | $420.00M | $421.10M | $426.70M | $516.40M | $585.30M | $716.50M | $736.00M | $737.00M | $555.10M |
Derived
| Metric | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross margin | 62.9% | 64.8% | 64.4% | 63.9% | 63.5% | 59.8% | 57.8% | 60.3% | 60.3% | 60.4% |
| Operating margin | -1.4% | 4.1% | 8.9% | 9.8% | 4.5% | -1.0% | -26.2% | -58.7% | -2.3% | -5.5% |
| FCF margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| SBC / revenue | 0.8% | 0.8% | 1.5% | 2.4% | 3.7% | 0.6% | 0.6% | 0.2% | 0.4% | 0.3% |
| Current ratio | 0.75x | 0.77x | 0.75x | 0.75x | 0.66x | 0.74x | 1.81x | 0.94x | 0.90x | 0.94x |
| Revenue YoY growth | -1.5% | -3.7% | 10.2% | 4.7% | 14.6% | -1.9% | -25.0% | -8.1% | -10.6% | Unavailable |
| Net margin | -10.4% | -6.2% | 1.5% | 9.1% | 4.9% | -4.3% | -21.3% | -60.2% | -2.5% | -5.5% |
| R&D / revenue | 2.1% | 2.1% | 2.1% | 1.9% | 1.8% | 2.1% | 2.0% | 1.6% | 1.6% | 1.8% |
| CapEx / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt / equity | 0.96x | 1.06x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | Unavailable | Unavailable | 46.5% | 25.8% | 38.6% | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open COTY in the interactive workspace to inspect any figure back to its filing.
Source filings
10-K · Filed 2026-08-20View SEC filing
10-Q · Filed 2026-05-05View SEC filing
10-Q · Filed 2026-02-05View SEC filing
10-Q · Filed 2025-11-05View SEC filing
10-K · Filed 2025-08-21View SEC filing
10-Q · Filed 2025-05-07View SEC filing
Reconciliation checks needing review
10 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
balance equationreview2025-06-30
Difference 94200000 exceeds tolerance 11907700.000. Presentation or filing-vintage differences need review.
balance equationreview2024-06-30
Difference 93600000 exceeds tolerance 12082500.000. Presentation or filing-vintage differences need review.
balance equationreview2023-06-30
Difference 93500000 exceeds tolerance 12661600.000. Presentation or filing-vintage differences need review.
balance equationreview2022-06-30
Difference 69800000 exceeds tolerance 12116100.000. Presentation or filing-vintage differences need review.
balance equationreview2021-06-30
Difference 84100000 exceeds tolerance 13691400.000. Presentation or filing-vintage differences need review.
balance equationreview2020-06-30
Difference 79100000 exceeds tolerance 16728800.000. Presentation or filing-vintage differences need review.
balance equationreview2019-06-30
Difference 451800000 exceeds tolerance 17710000.000. Presentation or filing-vintage differences need review.
balance equationreview2018-06-30
Difference 661300000 exceeds tolerance 22630200.000. Presentation or filing-vintage differences need review.
balance equationreview2017-06-30
Difference 551100000 exceeds tolerance 22548200.000. Presentation or filing-vintage differences need review.